All women with cancer in pregnancy should be managed within a MDT with expertise in this area and should have a named obstetrician by the first trimester. Continuity of care within the MDT is recommended
First‐trimester dating scan before commencing treatment, and second‐trimester anomaly scan and serial growth scans during treatment are recommended. A cervical assessment is recommended if the patient is at high risk of preterm labor
All women on chemotherapy or other treatment should have vaccinations as per local policies
NIPT testing should be avoided in women with known cancer in pregnancy
Maternal risks of sepsis, thrombosis, preterm delivery, CS, and postpartum hemorrhage should be considered and discussed
Fetal risks of miscarriage, structural defects if conceived on treatment, prematurity and related complications, low birth weight, and stillbirth should be considered and discussed
Consider low‐dose aspirin if the patient is at high risk of pre‐eclampsia, in line with the FIGO initiative
|